Delivery Order SPE2DB22D9367-SPE2DB24FSZ60

Award Date 9/9/24
Potential Completion Date 9/30/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $19,991.04 firm fixed-price delivery order is for the supply of 1,000 unit vials of the medication Kcentra. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the DLA to issue delivery...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,842.92 firm fixed-price delivery order contract is for the supply of 4,558,788,994 units of the drug Kcentra, a blood clotting factor used to treat bleeding disorders. The contract has no set-aside designation and is part of a larger $499,999,999 indefinite delivery contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,041.10 firm fixed-price delivery order is for the supply of Kcentra, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders...
This federal contract award, with an ID of SPE2DB22D9239|SPE2DB25FDE64, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $72,631.68 firm fixed-price delivery order is for the supply of 1,000 unit vials of the pharmaceutical product Kcentra. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a firm fixed-price delivery order valued at $8,727.84. The award was made by the Defense Logistics Agency (DLA), a defense agency, to fulfill the recurring pharmaceutical supply needs of military health facilities worldwide. The contract covers the delivery of 1,000-unit vials of the drug Kcentra to support the medical requirements of the Department of Defense (DoD)....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $9,977.28 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 500-unit vials of Kcentra, a blood coagulant medication, with a performance period ending on April 12, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, valued at up to $4,999,999, which enables...
This federal contract award is a delivery order (SPE2DB25FL0U0) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $28,700.64 firm fixed-price contract is for the delivery of 1,000 unit vials of the pharmaceutical product Kcentra. The award is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $27,311.36, is for the supply of 1,000 unit vials of the medication Kcentra. The delivery order was issued under a larger indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This IDC...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,961.04 contract is for the delivery of 500-unit vials of the medication Kcentra. The award is not associated with a set-aside designation. However, DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $42,918.72 firm fixed-price delivery order contract is for the supply of 4,566,006,905 units of the pharmaceutical product KCENTRA 1,000 UNIT VIALS. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program,...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB24FSZ60
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,188.00 firm fixed-price delivery order is for the supply of 1,000 unit vials of the medication Kcentra.

This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not utilize a small business set-aside.

Through this IDC and other prime vendor contracts, DMS Pharmaceutical Group provides both routine and critical medications, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the diverse medical requirements of the Department of Defense healthcare system.

Generated 12/9/24, 2:00 PM